Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]

Current treatment practices in metastatic castration resistant prostate cancer

Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo...

Current treatment practices in metastatic castration resistant prostate cancer ( Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo Berruti )

Prognostic biomarkers and next generation genomic sequencing

Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany

Prognostic biomarkers and next generation genomic sequencing ( Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany )

Primary and secondary resistance in colorectal cancer

Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy

Primary and secondary resistance in colorectal cancer ( Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy )

Highlights and goals of IMPAKT 2012

Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium

Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )

Molecularly characterising triple negative breast cancer

Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium

Molecularly characterising triple negative breast cancer ( Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium )

Neoadjuvant therapy and PCR through chemotherapy prior to surgery

Dr Michail Ignatiadis – Jules Bordet Institute, Brussels, Belgium

Neoadjuvant therapy and PCR through chemotherapy prior to surgery ( Dr Michail Ignatiadis – Jules Bordet Institute, Brussels, Belgium )

Overcoming drug resistance and targeting critical pathways

Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA

Overcoming drug resistance and targeting critical pathways ( Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA )

Heterogeneity of tumours and the challenges of biomarker development

Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy

Heterogeneity of tumours and the challenges of biomarker development ( Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy )

Targeting the PI3K/mTOR pathway

Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA

Targeting the PI3K/mTOR pathway ( Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA )

Endocrine therapy resistance and next generation sequencing

Prof Matthew Ellis - Washington University, USA

Endocrine therapy resistance and next generation sequencing ( Prof Matthew Ellis - Washington University, USA )

Molecular characterisation of breast cancer: the mutational landscape

Prof Sam Aparicio - University of British Columbia, Vancouver, Canada

Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )

Criteria required before implementation of whole genome arrays in clinical...

Prof Daniel Hays - University of Michigan, Ann Arbor, USA

Criteria required before implementation of whole genome arrays in clinical practice ( Prof Daniel Hays - University of Michigan, Ann Arbor, USA )

More from ecancer